Pancreatic Cancer Breakthrough: Daraxonrasib Doubles Survival in Key Trial

Imagine a daily pill that could nearly double survival time for advanced pancreatic cancer patients after other treatments fail. New...

13/04/2026

3 views

Eli Lilly’s New Obesity Drug Delivers Record Weight Loss

Eli Lilly just unveiled stunning results for their next-gen obesity drug: patients lost up to 28.7% of their body weight...

13/12/2025

5 views

Pfizer just pulled the plug on its obesity drug after a liver injury scare. How will this shake up the...

14/04/2025

0 views